Theodore Pincus to Glucocorticoids
This is a "connection" page, showing publications Theodore Pincus has written about Glucocorticoids.
Connection Strength
2.892
-
Long-term Glucocorticoid Use in Rheumatoid Arthritis. J Rheumatol. 2021 08; 48(8):1342.
Score: 0.734
-
Circadian use of glucocorticoids in rheumatoid arthritis. Neuroimmunomodulation. 2015; 22(1-2):33-9.
Score: 0.481
-
Clinical trials documenting the efficacy of low-dose glucocorticoids in rheumatoid arthritis. Neuroimmunomodulation. 2015; 22(1-2):46-50.
Score: 0.481
-
The past versus the present, 1980-2004: reduction of mean initial low-dose, long-term glucocorticoid therapy in rheumatoid arthritis from 10.3 to 3.6 mg/day, concomitant with early methotrexate, with long-term effectiveness and safety of less than 5 mg/day. Neuroimmunomodulation. 2015; 22(1-2):89-103.
Score: 0.481
-
Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis. Ann Intern Med. 2012 Aug 21; 157(4):299; author reply 300.
Score: 0.417
-
Are long-term very low doses of prednisone for patients with rheumatoid arthritis as helpful as high doses are harmful?. Ann Intern Med. 2002 Jan 01; 136(1):76-8.
Score: 0.200
-
RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories. J Rheumatol. 2008 Nov; 35(11):2136-47.
Score: 0.079
-
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther. 2008; 10(2):R30.
Score: 0.019